Andrea Wittig

Friedrich Schiller University Jena

Papers

1

Total Citations

11

H-Index

1

About

Andrea Wittig is a leading figure in radiation oncology, with a focused expertise in stereotactic body radiotherapy (SBRT), particularly for pulmonary tumors. Her major contribution lies in pioneering strategies to standardize dose prescription and delivery across different institutions and technologies, a critical challenge in modern radiotherapy. Her highly cited 2021 work, "Improving interinstitutional and intertechnology consistency of pulmonary SBRT by dose prescription to the mean internal target volume dose," directly addresses this by proposing a novel normalization approach that reduces variability in target dose coverage. With over 11 citations, this paper has become a key reference for harmonizing SBRT protocols, directly impacting clinical practice by enhancing treatment reproducibility and comparability across centers. Dr. Wittig’s research bridges the gap between advanced dosimetric planning and practical clinical implementation, ensuring that patients receive consistent, high-quality care regardless of the technology used. Her work is essential reading for students and researchers aiming to improve the robustness and reliability of stereotactic treatments.

Research Focus

Key Achievements

1
H-Index
1
Papers
11
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Improving interinstitutional and intertechnology consistency of pulmonary SBRT by dose prescription to the mean internal target volume dose
11 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 28
🏛 Institutions: Friedrich Schiller University Jena

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago